U.S. Marine and Shipping Stock News

The race to build bigger and more capable artificial intelligence models just took another leap with Moonshot AI’s open-source Kimi K3, and that move is already shaking up parts of China’s AI sector. When a 2.8 trillion parameter model is suddenly free to use and customize, the ripple effects can reach chip makers, software platforms, and large tech groups far beyond one country. This article picks out 3 stocks from our Artificial Intelligence (AI) Stocks screener that are directly exposed to...

Great Southern Bancorp (GSBC) opened Q2 2026 with total revenue of US$56.9 million and basic EPS of US$1.45, alongside trailing twelve month revenue of US$226.8 million and EPS of about US$6.06 that frame the latest quarterly print. Over recent periods the company has seen revenue move from US$224.3 million to US$229.2 million and then to US$226.8 million on a trailing basis, while TTM EPS has shifted from roughly US$5.88 to US$6.23 and then to US$6.06. This gives investors a clear view of...

Lululemon athletica (NasdaqGS:LULU) has invested in French nylon recycling startup Syntetica, aiming to integrate recycled materials into future product lines. The company has also opened a large automated distribution center in North America, focused on e-commerce fulfillment and regional logistics. Both moves reflect Lululemon's focus on supply chain sustainability and operational efficiency in its core athletic apparel business. Lululemon athletica has grown from a yoga-focused apparel...

Earlier in July, Alpha and Omega Semiconductor introduced the AOPL66801, an 80V half-bridge MOSFET using its new AmpStack vertically stacked packaging, aimed at high‑density power conversion applications from AI infrastructure to power tools, and priced at US$6.16 per unit for 1,000‑piece orders with a 16‑week lead time. This product’s integration of high‑side and low‑side MOSFETs into a single compact package highlights Alpha and Omega’s push toward higher‑value power solutions and...

Home BancShares (HOMB) has reported Q2 2026 results with total revenue of US$289.9 million and basic EPS of US$0.59, alongside net income excluding extra items of US$119.3 million. Over the past year, the company has seen total revenue move from US$260.1 million in Q1 2025 to US$289.9 million in Q2 2026, while quarterly EPS has ranged from US$0.58 to roughly US$0.63. Trailing twelve month EPS now stands at about US$2.42. With a net interest margin at 4.51% and a cost to income ratio just...

Iron Mountain has already announced it will report its second-quarter 2026 results on August 5 and host a same-day conference call, with materials available on its investor relations site. Analysts are watching the release closely as expectations for higher funds from operations align with management’s recently raised full-year 2026 earnings outlook. Now we’ll explore how the upgraded full-year earnings outlook may influence Iron Mountain’s existing investment narrative and risk-return...

ConocoPhillips (NYSE:COP) agreed to acquire a 42% interest in BP's Energy Company of Kirkuk Limited in northern Iraq. The deal provides access to over 3 billion barrels of oil equivalent in initial gross recoverable resources across four oil fields. The transaction adds new geographic exposure for ConocoPhillips and expands its international oil portfolio. ConocoPhillips is a large independent exploration and production company focused on oil and natural gas, and this Kirkuk agreement adds...

Cushman & Wakefield (NYSE:CWK) has released new sector reports highlighting a turning point across several real estate segments. The company points to strengthening U.S. apartment and industrial markets, resilient U.S. retail vacancy trends, and rising contractor confidence in Asia Pacific offices. These updates reflect shifting fundamentals following recent market challenges across core property sectors. Cushman & Wakefield, trading at around $14.05, sits at the center of these changing...

Johnson & Johnson (JNJ) just posted Q2 2026 revenue of US$25.3 billion and basic EPS of US$2.27, with trailing 12 month EPS at US$8.70 and net income of US$21.0 billion framing the latest quarter against a much larger earnings base. Over recent quarters the company has seen revenue move from US$23.7 billion in Q2 2025 through a range of roughly US$24.0 billion to US$24.6 billion, while quarterly EPS has tracked between US$2.10 and US$2.30 outside of a one off spike in early 2025. This sets a...

Greif stock has delivered a 54.1% return over the past 5 years, yet its current valuation screens as somewhat rich on market multiples and only middling on the broader checks. This raises the question of how much optimism is already in the price. A 54.1% 5 year return suggests Greif has rewarded patient shareholders, so investors now need to judge whether that strength is already reflected in the share price. Expectations around Greif's ability to sustain cash generation from its packaging...

GDS Holdings (NasdaqGM:GDS) is being highlighted as a key potential beneficiary of China's multi year national data center build out tied to accelerating AI adoption. The profile focuses on GDS's role within government backed digital infrastructure plans that prioritize high performance computing capacity for AI workloads. This policy driven push is presented as a material shift for data center operators positioned to support AI and cloud growth in China. GDS Holdings operates large scale...

New 25% U.S. tariffs on a wide range of Brazilian imports are reshaping trade routes, freight demand, and where goods enter key consumer markets. For global logistics and freight forwarding stocks, this kind of disruption can shift volumes, pricing power, and customer mix in ways that matter for portfolios. This article looks at three stocks from a Global Logistics and Freight Forwarding Companies screener that appear exposed to the latest tariff headlines in potentially positive ways, and...

Viking Therapeutics (VKTX) recently launched a Phase 1 single ascending dose study of VK3019, a Dual Amylin and Calcitonin Receptor Agonist being tested as a potential weight loss therapy in adults with obesity. See our latest analysis for Viking Therapeutics. The VK3019 update comes as Viking Therapeutics shares trade at $36.37, with the stock down 11.59% over the past week but up 22.66% on a 30 day share price return and supported by a very large 5 year total shareholder return of more than...

Why this leadership shake up at MBX Biosciences matters for investors MBX Biosciences (MBX) is in focus after the board promoted Executive Chairman Steve Hoerter to Chief Executive Officer and Chairman, while confirming John Smither as Chief Financial Officer, reshaping the company’s senior leadership team. See our latest analysis for MBX Biosciences. The leadership changes at MBX Biosciences arrive after a sharp run up in momentum, with the stock showing a 45.47% 1 month share price return...

Earlier this week, Power Integrations announced ultra-slim 15 W and 35 W auxiliary power supply reference designs tailored to NVIDIA’s Kyber 800 VDC AI data center architecture, using its InnoMux-2 ICs to cut board space and bill of materials by about 30 percent while maintaining at least 88 percent efficiency. By offering a compact alternative to bulkier silicon carbide-based designs for internal data center components, the company is aiming to embed its technology deeper into...

United Therapeutics stock has delivered a strong 5 year run, yet its current valuation checks still lean toward the shares looking inexpensive rather than stretched, even as recent insider selling and fresh clinical and regulatory news give investors more to weigh. United Therapeutics has returned 184.8% over the past 5 years, which puts extra focus on whether the current share price still reflects a reasonable entry point after such a long period of gains. Recent FDA approval for the LungFX...

John Wiley & Sons (WLY) has drawn fresh attention after appointing Frank Scognamiglio as Corporate Vice President and Chief Accounting Officer, while former CAO Christopher Caridi has shifted to a Senior Vice President, Business Transformation role. See our latest analysis for John Wiley & Sons. At a share price of $50.94, John Wiley & Sons has seen strong recent momentum, with a 30 day share price return of 12.97% and a year to date share price return of 72.68%, while the 3 year total...

Del Monte stock has delivered a 22.5% gain over the past three years, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current fundamentals while market multiples suggest the shares may still be priced below what the earnings profile implies. Over the last three years, Del Monte has returned 22.5%, which puts recent share price swings in the context of a longer period of steady, but not spectacular, gains. Recent...

Baidu announces a reported AI partnership with Apple focused on integrating its generative AI capabilities. The company also confirms a voluntary move to a dual-primary listing on the Hong Kong Stock Exchange. Both developments come as Baidu's NasdaqGS:BIDU shares last closed at $112.82. Baidu is back in focus after it reported a new AI partnership with Apple and outlined plans to convert to a dual-primary listing in Hong Kong. The stock, NasdaqGS:BIDU, has fallen 24.9% year to date but is...

Tech headlines have been busy, from Netflix and Alphabet share moves to questions around election betting and even pressure on private market giants like SpaceX. Sharp reactions such as an 8% drop in Netflix or a 4% slide in Alphabet can push investors to reassess what they are really paying for growth, cash flow and balance sheet strength. This article looks at three technology stocks from a value focused screener that appear especially exposed to these news catalysts. It outlines how each...

Stubborn import price pressure and talk of higher for longer rates are putting U.S. industrial and technology equipment stocks under a sharper spotlight, especially those tied to machinery, computers, and semiconductors. With Chinese import costs climbing and AI related hardware getting more expensive, some companies could see margins squeezed while others may find room to improve pricing power. This article explains how the latest data may affect a selection of large equipment manufacturers...

Booz Allen Hamilton Holding (BAH) recently reported fourth quarter fiscal 2026 adjusted earnings per share of $1.78, above the consensus estimate of $1.32, with earnings up 10.6% year over year. See our latest analysis for Booz Allen Hamilton Holding. Despite the earnings beat, Booz Allen Hamilton Holding’s recent share price return shows pressure, with the 30 day share price return down 11.8% and the year to date share price return down 23.1%. The 1 year total shareholder return is down...

On 7 July 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from both the S&P TMI Index and the S&P Global BMI Index, reducing its presence in widely followed equity benchmarks. This dual index removal matters because it can alter how index-tracking funds and benchmark-aware investors engage with ARI, potentially affecting trading patterns and liquidity. Next, we’ll examine how ARI’s removal from key S&P indices might influence its existing investment narrative and...

Trevi Therapeutics stock has delivered a very large 5 year return, yet the current valuation checks lean expensive rather than cheap, which raises the question of how much of that strength is already reflected in the price. Over the past 5 years, Trevi Therapeutics has returned about 7.6x, which sets a high bar for any further upside to be justified by fundamentals. Future progress in turning its drug pipeline into consistent revenue can support the current share price. The risk is that...